ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
21 hedge funds and large institutions have $26.3M invested in Zynerba Pharmaceuticals, Inc in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 0 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
21
Holding in Top 10
–
Calls
$191K
Puts
$315K
Top Buyers
| 1 | +$757K | |
| 2 | +$450K | |
| 3 | +$297K | |
| 4 |
PA
Perceptive Advisors
New York
|
+$255K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$218K |
Top Sellers
| 1 | -$1.74M | |
| 2 | -$391K | |
| 3 | -$113K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$111K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$87K |